Developing the Next Generation of iPSC Cell-Based Immunotherapies von Vizcardo, Raul, Klemen, Nicholas Donald, Islam, Rafiqul, Gurusamy, Devikala, Tamaoki, Naritaka, Jia, Li, Yu, Zhiya, Hennings, Amanda N, Maeda, Takuya, Bosch-Marce, Marta, Good, Meghan L, Pack, Svetlana, Stroncek, David F., Flomerfelt, Francis A, Kruhlak, Michael J, Restifo, Nicholas Phillip

Volltext

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting von Slaney, Clare Y, von Scheidt, Bianca, Davenport, Alexander J, Beavis, Paul A, Westwood, Jennifer A, Mardiana, Sherly, Tscharke, David C, Ellis, Sarah, Prince, H Miles, Trapani, Joseph A, Johnstone, Ricky W, Smyth, Mark J, Teng, Michele W, Ali, Aesha, Yu, Zhiya, Rosenberg, Steven A, Restifo, Nicholas P, Neeson, Paul, Darcy, Phillip K, Kershaw, Michael H

Volltext

Immune evasion by murine melanoma mediated through CC chemokine receptor-10 von Murakami, Takashi, Cardones, Adela R, Finkelstein, Steven E, Restifo, Nicholas P, Klaunberg, Brenda A, Nestle, Frank O, Castillo, S Sianna, Dennis, Phillip A, Hwang, Sam T

Volltext

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice von Amos, Sally M., Pegram, Hollie J., Westwood, Jennifer A., John, Liza B., Devaud, Christel, Clarke, Chris J., Restifo, Nicholas P., Smyth, Mark J., Darcy, Phillip K., Kershaw, Michael H.

Volltext

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Commentary von DARCY, Phillip K, HINRICHS, Christian S, RESTIFO, Nicholas P, SPOLSKI, Rosanne, PAULOS, Chrystal M, GATTINONI, Luca, KERSTANN, Keith W, PALMER, Douglas C, KLEBANOFF, Christopher A, ROSENBERG, Steven A, LEONARD, Warren J

Volltext